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Abstract
OBJECTIVES—To determine whether an online support tool can impact anxiety in women 
experiencing an abnormal mammogram.
MATERIALS AND METHODS—We developed an online support system using the 
Comprehensive Health Enhancement Support System (CHESS) designed for women experiencing 
an abnormal mammogram as a model. Our trial randomized 130 of these women to online support 
(the intervention group) or to a list of five commonly used Internet sites (the comparison group). 
Surveys assessed anxiety and breast cancer worry, and patient satisfaction at three important 
clinical time points: when women were notified of their abnormal mammogram, at the time of 
diagnostic imaging, and at the time of biopsy (if biopsy was recommended).
RESULTS—Study participants in the intervention group showed a significant decrease in anxiety 
at the time of biopsy compared to the comparison group (p=0.017). However, there was no 
significant difference in anxiety between the intervention group and the comparison group at the 
time of diagnostic work-up. We discontinued assessment of patient satisfaction after finding that 
many women had substantial difficulty answering the questions that referenced their physician, 
because they did not understand who their physician was for this process of care.
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CONCLUSION—The combination of the inability to identify the physician providing care during 
the mammography work-up and anxiety effects seen only after an interaction with the breast 
imaging team may indicate that online support only decreases the anxiety of women in concert 
with direct interpersonal support from the healthcare team.
Introduction
Screening mammography reduces breast cancer mortality through earlier detection of 
smaller, more curable cancers (1). Of all screening mammograms, approximately 10% will 
be found to be abnormal and require additional evaluation, but only 0.1% to 0.5% of women 
who undergo screening mammography will actually be diagnosed with breast cancer (2). 
This means that despite a highly specific screening test (>90%), the vast majority of 
abnormal exams are false positives. False positive examinations lead to additional studies, 
such as diagnostic mammograms and ultrasound, and even biopsy procedures (3). This can 
result in anxiety, which could have a negative impact on future screening behaviors (3–6). 
Therefore, an intervention that decreases anxiety would be useful.
The impact of an abnormal mammogram on women’s psychological well-being is an active 
area of research (3, 4, 6–10). Some women develop considerable psychological distress, 
particularly anxiety (3), at the time of abnormal mammography (11–14). For example, 16% 
of women felt certain they had breast cancer (15), and about 30% felt “very anxious” after 
receiving the letter notifying them of an abnormal result (the “recall letter”) (15). Prolonged 
waiting periods between the time of the screening mammogram and the diagnostic 
mammogram can also increase anxiety (16, 17). The literature reflects variable findings 
regarding how long anxiety continues after false positive mammography, with some studies 
reporting a range from several months to as long as 3 years (13–15, 17–23). During the 
diagnostic workup, women rely on social support networks (24) and educate themselves 
about breast cancer to manage their anxiety and prepare for a diagnosis (25–27), suggesting 
that tailored information in the form of an online support module may help women during 
this period, when few quality resources are available and many questions remain 
unanswered. Interaction with a healthcare provider (17, 28), but not basic informational 
materials (29), is effective at reducing anxiety.
The Internet has become a primary source for health information and emotional support for 
patients (30); however, the information provided is often of poor quality (31–32) and 
patients frequently remain without information until interacting with healthcare staff. The 
Comprehensive Health Enhancement Support System (CHESS) has been shown to improve 
women’s ability to seek out information and obtain support after a breast cancer diagnosis 
(33). CHESS is a computer-and web-based tool that incorporates searchable health 
information, an interactive component that guides patients by making suggestions and 
giving feedback, and a module that links them electronically with other patients with breast 
cancer. For this project, we implemented an online support module (Early CHESS), which 
modifies the health information features of CHESS to focus on women with abnormal 
screening mammogram results.
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The purpose of this pilot study was to evaluate the impact of Early CHESS on women with 
an abnormal screening mammogram by assessing anxiety, breast cancer worry, and patient 
satisfaction with the radiologist.
Materials and Methods
Clinical process
The study procedure was integrated into the standard clinical process at the University of 
Wisconsin (UW) Breast Center (see Figure 1). After a screening mammogram is performed 
on an asymptomatic woman, the images are evaluated by a radiologist. A decision is then 
made to either return the patient to routine screening or recall the patient for additional 
imaging. If diagnostic mammography is indicated to work-up an abnormality, the patient 
receives a phone call from a nurse, is sent a recall letter, and the primary care physician is 
notified. At the follow-up appointment, a diagnostic mammogram is performed, providing 
the first opportunity for the patient to interact in person with clinical staff since the receipt of 
the recall letter (Figure 1). After the radiologist evaluates the diagnostic mammogram, a 
decision is then made to return the patient to routine screening, recommend a six-month 
follow-up, or recommend a biopsy. A biopsy is recommended when the findings on 
mammography are concerning and tissue sampling is warranted for further evaluation. At 
the UW Breast Center, patients always meet with a radiologist if a diagnostic ultrasound is 
performed or if a biopsy is recommended.
Power and Sample Size
Based on our previous experience with online support for breast cancer, we estimated a 10% 
drop out rate over the study period. We also anticipated that some assessments would be 
missing for other reasons. Given an anticipated moderately small treatment effect size of .4 
s.d. with a power of 80%, a one-tailed alpha of .05, and baseline-outcome measure 
correlations of .60, we concluded that we would need a completed sample size of 102. We 
thus decided to recruit a total sample of 130, in order to accommodate for attrition or 
missing data.
Recruitment
After Institutional Review Board (IRB) approval was obtained, recruitment was conducted 
from June 2010 to November 2011. Inclusion criteria included: women who were >21 years 
old, able to read and understand English, had access to the Internet, and were being recalled 
for diagnostic imaging after a screening mammography. The women were invited to 
participate by nurses who notified them of their abnormal mammogram, which occurred 
prior to the receipt of the recall letter notifying them of their abnormal results. After 
permission was obtained, a research staff called each woman, explained the details of the 
study, answered questions, obtained verbal consent, collected contact information and 
demographic data, and the baseline survey questionnaire was completed. At the time of 
enrollment, the research staff confirmed the participant’s recall appointment time and met 
the patient at the UW Breast Center to complete the second survey and obtain written 
consent.
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Once the research staff completed verbal consent and the baseline telephone survey, 
participants were randomized via a computer-generated list that was accessed by the study 
director. Each participant was informed of her randomization group. The comparison group 
received a list of five credible breast imaging websites (see Appendix 1) via email. Subjects 
randomized to the intervention (Early CHESS) group received an email with instructions for 
accessing the Early CHESS website, including login information.
The Online Support Module
Early CHESS was developed by the UW’s Center for Health Enhancement Systems Studies 
and includes breast health, imaging and expert content in a variety of formats, including 
Q&As, web links and articles. Early CHESS also has content on breast cancer diagnosis and 
treatment.
Survey Instruments
The impact of Early CHESS was evaluated in two domains: (1) anxiety and breast cancer 
worry and (2) patient satisfaction with their physician interaction during three time points by 
the research coordinator (Figure 1). The baseline survey was completed by phone at 
enrollment. The second assessment was conducted at the time of the diagnostic appointment, 
immediately prior to diagnostic breast imaging (usually within 2–3 days of the notification 
letter), and the third assessment (for the women needing biopsy) was completed after 
meeting with the breast imaging team (nurse and radiologist) and immediately before the 
biopsy procedure (usually within 1 week of the notification letter).
Anxiety and Breast Cancer Worry—Previously validated psychometric questionnaires 
were used to assess women’ anxiety and breast cancer worry.
• State anxiety was measured using the State Anxiety (SA) subscale of the State-
Trait Anxiety Inventory (STAI) (34) at all three time points. Items were rated on a 
0 to 3 Likert-type scale with scores calculated as item sums with a possible range of 
0 to 60, higher scores indicating greater state anxiety. For our sample, cronbach’s 
alpha was 0.94 at initial baseline administration (n=126).
• The Breast Cancer Worry subscale of the Lerman Breast Cancer Worry Scale 
(LBCWS) (35), designed specifically to assess the constructs of breast cancer 
worry, was also administered at all three time points. This single item, “How 
worried are you about getting breast cancer someday?” was rated on a 0 (“Not at 
all”) to 4 (“Almost all the time”) Likert scale.
Patient satisfaction—The Patient Satisfaction with Doctor Questionnaire (PSQ-MD) 
(37) was administered at all three time points. This scale has two subscales: Physician 
Disengagement and Perceived Support, with items rated on a 0 to 3 Likert scale and scores 
calculated as item sums with a possible range of 0 to 72. Cronbach’s alpha was 0.89 (n=20) 
and 0.86 (n=15), respectively, at baseline.
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Demographic variables—Data on potentially confounding variables, such as age, 
education, personal health history, family history of breast cancer, and previous abnormal 
screening mammography, were collected at the time of consent. The time course of 
notification, enrollment and follow-up appointments was also recorded.
Statistical Analysis
The STAI and LBCWS measures were obtained for each of the three time points: at baseline 
(Pre), at diagnostic mammogram (Dx) and at biopsy (Bx). Change scores across time points, 
expressed as a percentage, were obtained and summarized with quartiles (see Appendix 2). 
Differences between the intervention (Early CHESS) and comparison groups for each 
change measure were assessed with Kruskal-Wallis tests. P < 0.05 (two-sided) was used as 
the criterion for statistical significance. There was no adjustment for multiple comparisons. 
Statistical analyses and graphics were performed using R statistical software (version 2.12.1; 
R Development Core Team) (38).
Results
Population characteristics and demographics
179 women were initially approached for study participation (Figure 2), with 130 women 
ultimately being enrolled in the study and randomized to one of two groups, the Early 
CHESS group or the comparison group. Seven (7) women dropped out of the study after 
enrollment (two were from the comparison group and five were from the Early CHESS 
group) for one of several reasons: felt too overwhelmed to participate, no longer interested, 
had diagnostic evaluation at a different facility, or had a breast MRI rather than biopsy. One 
of these seven women dropped out after giving consent, but before the baseline survey and 
demographic data were obtained. Therefore, baseline survey and demographic data were 
collected on 129 women (65 in the comparison group and 64 in the Early CHESS group).
Each study participant was asked to indicate the age range that describes her current age, 
with the majority of the participants being within the American College of Radiology (ACR) 
recommended mammography screening age range. The overall age distribution was similar 
for both the comparison and the Early CHESS groups.
Majority (98%) of the study participants were Caucasian. The study population overall was 
well educated, with 67% of the comparison group and 69% of the Early CHESS group 
reporting having a four-year college degree or higher. Thirty-five women in the comparison 
group had a family history of breast cancer, compared to twenty-four women in the Early 
CHESS group. The majority of the participants in this study (86%) noted a personal history 
of abnormal mammogram and/or biopsy (Figure 3).
Twenty-three women (35.4%) in the comparison group went on to have a biopsy, compared 
to 20 (31.3%) of the women in the Early CHESS group. The average amount of time 
between the time of the baseline survey and the diagnostic appointment was 3.5 days for the 
comparison group, and 5.1 days for the Early CHESS group; while the mean number of days 
between the diagnostic appointment and the time of biopsy was 14 days for the comparison 
group, and 9.6 days for the Early CHESS group.
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Impact on patient anxiety
At baseline, the State Anxiety (SA) scores had a mean of 21.35 (SD=13.43) for the 
comparison group, and a mean of 17.12 (SD=10.55) for the Early CHESS group. There was 
a significant difference in the change scores (see Appendix 2) for SA between the 
comparison group and the Early CHESS group at biopsy (p=0.02), but not at the time of 
diagnostic work-up (p=0.24). The median percent change score for SA for the comparison 
group at the time of diagnostic work-up was −11.03 (−44.29, +16.01; i.e. first quartile, third 
quartile), while the corresponding score for the Early CHESS group was −22.73 (−43.95, 
+7.28), p=0.24 (see Figure 4 for box and whisker plots).
The median percent change score for SA for the comparison group at biopsy was 0.00 
(−22.71, +30.09), compared to the Early CHESS group of −40.91 (−128.10, −15.00), p= 
0.02 (Figure 5).
Impact on patient breast cancer worry
There was no significant difference in the percent change scores for the Breast Cancer 
Worry subscale between the comparison group and the Early CHESS group, either at 
diagnostic work-up (p=0.60) or at the time of biopsy (p=0.72).
Impact on patient satisfaction
Patient satisfaction was not included in the data analysis because many of the study 
participants had difficulty answering questions pertaining to satisfaction with their physician 
interaction. Patients expressed uncertainty about which physician was directing this process 
of care and which physician interaction to evaluate. Consequently, we stopped collecting 
data pertaining to patient satisfaction. This change was made after 33 women had received 
the survey.
Discussion
Established social support networks and access to reliable information have been identified 
as important needs of women undergoing mammography (27–29). This pilot study is 
important because it extends the use of CHESS to the pre-diagnosis stage of breast cancer, 
in contrast to the conventional use of CHESS, which was directed towards women with 
newly diagnosed breast cancer navigating treatment decisions (39–43).
The results of this study show that Early CHESS decreased anxiety in women who 
experienced an abnormal screening mammogram at the time of biopsy, but not at diagnostic 
work-up. It is important to note that the second assessment was performed when the women 
presented for their diagnostic mammogram, prior to any interaction with the breast imaging 
team. However, the third assessment was performed just prior to biopsy (for those needing 
biopsy), after the women had interacted with members of the breast imaging team. These 
results may suggest that when combined with interactions with a care team, Early CHESS 
helps to decrease the anxiety associated with abnormal screening mammograms. This 
difference could also be explained by increased motivation of the study participants who 
have been recommended for biopsy to use Early CHESS.
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A potential reason for the absence of a significant difference in the breast cancer worry 
between both groups is that the LBCWS assesses long-term worry, rather than immediate 
anxiety like the SA, which would be harder to impact during the short duration of this study. 
Another possible limitation of this study is the large percentage of the study participants 
who had previously had an abnormal mammogram and/or breast biopsy (Figure 3), as this 
may have reduced the impact of Early CHESS on these women. Additionally, only a small 
number of women went on to biopsy, which could have limited our ability to detect the 
impact of Early CHESS on the study participants who went on to have a biopsy.
Potential directions for future research include evaluation of how much time women need to 
spend using the Early CHESS system in order to experience a significant decrease in 
anxiety, and which components of the Early CHESS system have the most impact on patient 
anxiety.
We did not include patient satisfaction in our analysis, because we found that many of the 
participants could not answer the questions assessing satisfaction with their physician 
interaction. This was mainly because these women did not know who their physician was for 
this process of care and which physician interaction to evaluate, and is likely due to the fact 
that they did not have a physician taking responsibility for this interaction. This discovery 
indicates a problem in the system of care and may underscore an opportunity to clarify roles, 
responsibility, and ownership of patient interactions, particularly in multidisciplinary care 
settings.
These results have clinical implications for the field of breast imaging, where anxiety in 
women undergoing screening mammography has increasingly been recognized as an 
important issue. In 2009, the US Preventive Services Task Force revised their 
recommendation for breast cancer screening with mammography in women between the 
ages of 40 and 49, based in large part on the perceived harms (including anxiety) related to 
false positive mammograms (2). The willingness to forego the mortality reductions of 
mammography in order to avoid such harms underscores the importance of better 
quanitifying, understanding and reducing anxiety related to breast cancer screening. 
Therefore, using tools such as Early CHESS to help reduce anxiety may be useful.
In conclusion, Early CHESS may decrease anxiety in women who experience abnormal 
screening mammograms, when combined with interactions with the breast imaging team. 
Early CHESS was designed to empower women to seek more information regarding 
abnormal mammograms and to get their questions answered, but the results of this study 
indicate that earlier in the work-up process, when there is not an identifiable care team (as 
indicated by inability to complete patient satisfaction surveys), providing a resource like 
Early CHESS may not help to reduce anxiety. However, after interacting with a healthcare 
provider, once women have an identifiable care team, they are better able to employ the 
coping mechanisms and information that Early CHESS provides to potentially reduce 
anxiety. This indicates that the combination of both Early CHESS and the interaction 
between the patient and her clinician is important in helping to reduce anxiety.
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Appendix 1
LIST OF 5 WEBSITES GIVEN TO THE COMPARISON GROUP: These five websites 
were selected because they were the five most highly used weblinks in the CHESS module 
and they represented some of the most widely known and trusted websites for providing 
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http://ww5.komen.org/breastcancer/earlydetectionampscreening.html
Appendix 2
For each patient, the change score for STAI at the time of diagnostic work-up (STAI.Dx) 
was calculated by subtracting the STAI score at baseline from the score at the time of 
diagnostic work-up (i.e. STAI.PreDx = STAI.Dx − STAI.Pre). The percent change in STAI 
at diagnostic work-up was then calculated by taking the ratio of the change score to the 
baseline score, and multiplying by 100 (i.e. STAI.pctPreDx = 100 × [STAI.Dx − STAI.Pre]/
STAI.Pre). The percent change in STAI at the time of biopsy was similarly calculated by 
taking the ratio of the change score for STAI at biopsy to the baseline score, and multiplying 
by 100 (i.e. STAI.pctPreBx = 100 × [STAI.Bx − STAI.Pre]/STAI.Pre). Percent change 
scores for the LBCWS measure at diagnostic work-up and at the time of biopsy were 
similarly calculated. Summary measures (mean, median, standard deviation and extremes) 
were then obtained and depicted via box and whisker plots for each change score.
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